Uploaded July 2026 | Updated September 2026, 3 weeks ago
Linked videos:
youtu.be/AceEPcPQSJE
youtu.be/eLcr9TOJ3G4
youtube.com/playlist?list=PLXoKcD0kKb9a1Ldd01TQfoPtPOYaxTNWg
Sources:
1. Hristakeva S. The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand.
2. GLP-1 Analogues Market Size to Hit USD 1,062.90 Billion by 2035. Accessed July 26, 2026. precedenceresearch.com/glp-1-analogues-market
3. Mahase E. GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment. BMJ. 2024;386:q1645. doi:10.1136/bmj.q1645
4. Watson E. From ‘GLP-1 companion foods’ to ‘Nature’s Ozempic…’ What the new breed of weight loss drugs means for the food industry. AgFunderNews. January 23, 2024. Accessed July 26, 2026. agfundernews.com/from-glp-1-companion-foods-to-natures-ozempic-what-the-new-breed-of-weight-loss-drugs-means-for-the-food-industry
5. Gonzalez-Rellan MJ, Drucker DJ. The expanding benefits of GLP-1 medicines. Cell Rep Med. 2025;6(7):102214. doi:10.1016/j.xcrm.2025.102214
6. Read 1 Min. GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034. BioSpace. July 14, 2025. Accessed July 26, 2026. biospace.com/press-releases/glp-1-receptor-agonist-market-valued-at-usd-62-86-billion-in-2025-set-to-grow-at-17-5-cagr-through-2034
7. Tang H, Zhang B, Lu Y, et al. Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation. BMJ. 2026;394:e100077. doi:10.1136/bmj-2026-100077
Linked videos:
youtu.be/AceEPcPQSJE
youtu.be/eLcr9TOJ3G4
youtube.com/playlist?list=PLXoKcD0kKb9a1Ldd01TQfoPtPOYaxTNWg
Sources:
1. Hristakeva S. The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand.
2. GLP-1 Analogues Market Size to Hit USD 1,062.90 Billion by 2035. Accessed July 26, 2026. precedenceresearch.com/glp-1-analogues-market
3. Mahase E. GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment. BMJ. 2024;386:q1645. doi:10.1136/bmj.q1645
4. Watson E. From ‘GLP-1 companion foods’ to ‘Nature’s Ozempic…’ What the new breed of weight loss drugs means for the food industry. AgFunderNews. January 23, 2024. Accessed July 26, 2026. agfundernews.com/from-glp-1-companion-foods-to-natures-ozempic-what-the-new-breed-of-weight-loss-drugs-means-for-the-food-industry
5. Gonzalez-Rellan MJ, Drucker DJ. The expanding benefits of GLP-1 medicines. Cell Rep Med. 2025;6(7):102214. doi:10.1016/j.xcrm.2025.102214
6. Read 1 Min. GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034. BioSpace. July 14, 2025. Accessed July 26, 2026. biospace.com/press-releases/glp-1-receptor-agonist-market-valued-at-usd-62-86-billion-in-2025-set-to-grow-at-17-5-cagr-through-2034
7. Tang H, Zhang B, Lu Y, et al. Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation. BMJ. 2026;394:e100077. doi:10.1136/bmj-2026-100077
